US4342651A - Process and apparatus for producing sterilized and bacteria-free water - Google Patents

Process and apparatus for producing sterilized and bacteria-free water Download PDF

Info

Publication number
US4342651A
US4342651A US06/130,390 US13039080A US4342651A US 4342651 A US4342651 A US 4342651A US 13039080 A US13039080 A US 13039080A US 4342651 A US4342651 A US 4342651A
Authority
US
United States
Prior art keywords
filter
deionized water
line
water
permeate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US06/130,390
Inventor
Ulrich E. Ahrens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AHRENS ULRICH E DR
Original Assignee
Blutspendedienst der Landsverbande des Deutschen Roten Kreuses
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blutspendedienst der Landsverbande des Deutschen Roten Kreuses filed Critical Blutspendedienst der Landsverbande des Deutschen Roten Kreuses
Application granted granted Critical
Publication of US4342651A publication Critical patent/US4342651A/en
Assigned to AHRENS, ULRICH E., DR. reassignment AHRENS, ULRICH E., DR. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: BLUTSPENDEDIENTST DER LANDESVERBANDE DES DEUTSHEN ROTEN KREUZES NIEDERSACHEN OLDENBURG AND BREMEN GMBH
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022Filtration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/025Reverse osmosis; Hyperfiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/08Flat membrane modules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/10Spiral-wound membrane modules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D71/00Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06Organic material
    • B01D71/30Polyalkenyl halides
    • B01D71/32Polyalkenyl halides containing fluorine atoms
    • B01D71/36Polytetrafluoroethene
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A20/00Water conservation; Efficient water supply; Efficient water use
    • Y02A20/124Water desalination
    • Y02A20/131Reverse-osmosis

Definitions

  • This invention relates to a process and apparatus for obtaining highly pure, sterilized, particle, pyrogen and germ-free water for medicinal injection preparations and other technical purposes, using completely salt-free or deionized water and a reverse osmosis filter.
  • Reverse osmosis using semipermeable membranes has been employed in which water of low salt content is separated from a salt-containing water. If such a membrane is subjected to a salt containing water under a pressure exceeding the osmotic pressure of the solution, water of low salt content passes through and germs or bacteria and pyrogens are also retained by the membrane.
  • Reverse osmosis can be used to remove germs, bacteria and pyrogens from water which has previously been deionized by any conventional means.
  • Membranes which have been used for this purpose have been formed of acetyl celluloses, polyamides or polyolefins. Water transportation through the membranes is impeded by the concentration or polarization that occurs of retained substances. By a suitable excess flow oriented tangentially to the surface, such concentration and polarization can be reduced and the membrane surface can be largely kept clear of microscopic and larger bodies such as germs, bacteria and pyrogens.
  • the disadvantage of the known processes and apparatus comprising the semipermeable membranes is, however, that the membranes must be continually subjected to the action of water, in order that the semipermeable membranes are not damaged by bacteria which are unable to pass through the membranes. If the installation is shut down and no water flow takes place over the membrane, colonies of bacteria can form which attack the membrane, so that when operation is resumed germs will pass through the fairly large holes which are now present. On the other hand, a requirement for such pure water usually does not exist continuously, or the requirement for pure water is highly fluctuating, so that a solution must be found for collecting and storing the sterile permeate under sterile conditions.
  • a further disadvantage is that, due to the particular nature of the above-described process of reverse osmosis, a considerable proportion of the water supplied to the semipermeable membrane serves only as excess water for maintaining at the surface of the membrane a flow of water for the above-mentioned reasons.
  • the present inventor has discovered that even though recycling of a portion of the deionized water removes substantial amounts of bacteria from the filter surfaces and reduces the likelihood of attack on the membrane, some bacteria still remains which will attack the membrane and eventually a certain amount of bacteria will enter the permeate at these points of attack. Moreover, in the prior systems it has been generally necessary to recycle a substantial amount of the deionized water to insure that a sufficient flushing action occurs at the membrane surface to delay for as long as possible attack of the membrane by the bacteria. Such substantial recycling of the deionized water is not only wasteful of pumping energy, but also results in reduced system capacity and increased cooling requirements to cool the recycled water which is heated by the pumping energy necessitated by such recycling.
  • the inventor has also discovered that where sterilizing fluids have been periodically employed to flush the prior systems, that the membranes of these systems were not of sufficient configuration to enable the sterilant to reach all portions of the membrane surfaces. Thus, the membranes were subjected to attack by bacteria on those portions of their surfaces which could not be reached by the sterilizing fluid and bacteria escaped into the permeate.
  • the process and apparatus incorporating the principles of the present invention is capable of producing a consistently sterile, bacteria and pyrogen-free permeate suitable for medicinal injections and other purposes contrary to the aforementioned Goodall publication and overcome all of the aforementioned disadvantages of the prior systems.
  • the process and apparatus incorporating the principles of the present invention achieves this result while at the same time minimizing energy and capital requirements and maximizing capacity.
  • a process for producing sterilized water free of bacteria and pyrogens and suitable for medicinal injection includes the step of circulating deionized water into contact with a reverse osmosis-filter formed of a material which is substantially impervious to attack by bacteria in the water. A portion of the deionized water is passed through the filter to obtain a sterile permeate and another portion is recycled from the filter. The sterile permeate which is not used is also recycled to the filter. At least periodically all portions of the surface of the filter are sterilized with a sterilizing fluid.
  • apparatus for producing sterilized water free of bacteria and pyrogens and suitable for medicinal injection comprises a source of deionized water, a reverse osmosis filter formed of a material which is substantially impervious to attack by bacteria in the water, means for supplying the deionized water from the source to and into contact with the filter and passing a portion of the deionized water through the filter to obtain a sterile permeate.
  • the apparatus also includes means for recycling another portion of the water which is not passed through the filter from the filter and means removes the sterile permeate from the filter withdraws the permeate for use and recycles the remainder of the permeate to the filter.
  • Means at least periodically supplies a sterilizing fluid to the filter and the filter is constructed and arranged such that all portions of its surface are exposed to the sterilizing fluid.
  • the filter which is impervious to bacteria attack is formed of a fluorine substituted polymer.
  • the filter is arranged in coil or plate form to enable the sterilizing fluid to reach all portions of the surface thereof.
  • FIG. 1 is a schematic diagram illustrating the operation of the preferred embodiment of the invention for obtaining pure water, the path of the supplied deionized water being shown in chain-dotted lines and the path of the permeate in dotted lines,
  • FIG. 2 is a view similar to FIG. 1 and illustrates the operation when no permeate is being removed, but deionized water is being supplied from a deionization plant,
  • FIG. 3 is a view similar to FIG. 2 and illustrates the operation when no deionized water is supplied from the plant
  • FIG. 4 is a view similar to FIG. 3 and illustrates the operation when the circuit is being sterilized.
  • deionized water which is derived from a deionization plant P and which is to be treated is supplied along an inlet line 1 and flows in the direction of the arrow through a shut-off valve V1, a solenoid valve MV1 and a non-return valve R1 into a supply line 9 which includes a pressure-reducing valve RV, a further shut-off valve V2 and a first prefilter VF1.
  • the water leaving the prefilter VF1 flows into a second prefilter VF2, through a shut-off valve V3 and finally through a sampling station StE1 to a pump DP2 which generates the pressure necessary for operating the reverse osmosis filters RO1 and RO2, the pressure being between 10 and 80 bars according to the type of filter.
  • the balance of the supplied deionized water flows through line 3 and a valve V4 into a compensating vessel B and fills this vessel until the upper level mark NRo of the level regulator is reached.
  • the vessel B has an outlet communicating with a return line 6 which includes a pump DP1 which is switched on by the level regulator NRo when a predetermined liquid level is reached so that liquid is returned along line 6 into the deionization plant P until the level NRu is reached in the vessel B.
  • This return flow along line 6 passes through a non-return valve R3, a solenoid valve MV4 and a shut-off valve V7. Between the solenoid valve MV4 and the shut-off valve V7 an emptying line containing a shut-off valve V8 is incorporated as a branch.
  • manometers M1 to M3 are preferably disposed as illustrated.
  • permeate is drawn off along outlet line 5 for use and a portion of the supplied deionized water is recycled along return line 6 to the deionization plant P.
  • FIG. 2 the circuit arrangement is shown when no permeate is drawn from the outlet line 5, but the deionization plant P is still in operation.
  • a recycle line 4 connects the discharge line 2 to the compensating vessel B and is branched off between the sterile sampling station StE2 and the valve MV2, just upstream of the latter.
  • a solenoid valve MV3 is disposed, which is open when no permeate is drawn off, but is closed when permeate is drawn off.
  • FIG. 2 illustrates the operating state in which no permeate is being withdrawn and the permeate together with a proportion of the supplied deionized water is supplied to the deionization plant P which is supplying the deionized water.
  • a short-circuit line 8 incorporating a normally closed solenoid valve MV5 and a non-return valve R2 connects the return line 6 to the supply line 1 from a position upstream of the non-return valve R3 to a position between the valves R1 and RV.
  • the pressure PD1 sensed by the pressure monitor D1 is smaller than a predetermined critical pressure PD1 crit., and this operates to close valves MV1 and MV4 and open valve MV5.
  • MV2 is closed or held closed and MV3 is opened or held open.
  • the pump DP2 is switched off.
  • the pump DP1 maintains a weak circulation through the entire plant, as can be seen from the switching diagram below of the plant. In this condition of the circuit, the supplied deionized water and the permeate are circulated in a closed circuit or loop.
  • the compensating vessel B is equipped with a connecting line 7, through which a sterilizing disinfecting agent, for example a 2% formalin solution, can be periodically introduced.
  • a sterilizing disinfecting agent for example a 2% formalin solution
  • This formalin solution when supplied, flows out of the vessel B through the pump DP1, along the line 8 into the line 9 leading to the prefilters, through the pump DP2, and then partially as an excess portion back into the compensating vessel B, and also through the reverse osmosis filters RO1 and RO2, through the lines 2 and 4 back into the compensating vessel B, because the solenoid valve MV3 is opened, but the solenoid valve MV2 is closed.
  • a breathing filter AF is provided, through which a sterile ventilation of the compensating vessel B can be carried out.
  • the change-over from the operating state according to FIGS. 1 and 2 into the operating state with its function according to FIG. 4 can be carried out in practice automatically either after the elapse of specific periods or after specific quantities have flowed through.
  • the valves MV1, MV2 and MV4 would be closed and a disinfecting agent introduced into the compensating vessel through the line 7, optionally together with water as a diluting agent.
  • the water contained in the plant can be entirely or partially discharged from the vessel B through a line 10 after opening a valve V5 in the line 10. The arrangement and layout should take account of this accordingly.
  • the compensating vessel B or another location of the circuit may be equipped with a thermoprobe which measures the temperature of the water in the circuit and switches appropriate electric circuits which, by switching off pumps or switching on cooling means, leads to a reduction in the temperature of the water in the circuit.
  • the level controller in the compensating vessel B can be equipped with a contact such as NRs for switching off the pressure pump DP1 and triggering an alarm.
  • PD1 crit. critical pressure, which is smaller than the lowest full deionization water pressure with the deionization plant P in operation. Objective: switching over from operating method 1 or 2 to 3, when the deionization plant P goes out of operation or other pressure failure takes place upstream of D1.
  • RV pressure reducing valve
  • StE sterile sampling
  • RO reverse osmosis plant
  • the two reverse osmosis filters RO1 and RO2 should be adapted to one another and may be designed, for example, for a permeation rate per hour of 80 l.
  • the pump then produces a pressure of, for instance, 14 bars.
  • the volume of the compensating vessel B is then, for example 100 l and the total volume of the plant will be 120 l, depending upon the length of the lines 2 and 4.
  • the pump DP1 is designed according to the characteristics of the reverse osmosis filters and the flocking characteristic of the pump DP2, that is the characteristic when this pump is shut down.
  • the process and apparatus of the present invention offers a system in which the recycling of a portion of the dionized water with or without the permeate impairs colonies of bacteria forming at the membrane of the reverse osmosis filter even under circumstances where there is no demand for the permeate.
  • it has been found that such recycling of deionized water is not sufficient to prevent eventual attack of the membrane by colonies of bacteria.
  • this attack can be prevented by two additional features.
  • One feature is to employ a membrane material which is substantially impervious to bacteria attack so that even if some bacterial growth is experienced on the membrane, the membrane will remain intact.
  • the other feature is to employ a membrane construction and arrangement which can be contacted over its entire surface by the sterilizing disinfecting agent during the sterilizing portion of the cycle of operation.
  • a reverse osmosis filter or membrane formed of a halogenated polymer is substantially impervious to bacteria attack.
  • a preferred membrane material for this purpose, and to which bacteria do not easily attach, is a fluorine substituted polymer.
  • Such membrane sheets may be formed as described in 21 Journal of Applied Polymer Science, 1977, pp. 3269-3290.
  • membrane materials which are suitable for use in the present invention include homo- and copolymers of polytetrafluoroethylene and polytrifluorochroroethylene.
  • polytetrafluoroethylene may have the following properties:
  • polytrifluorochloroethylene may have the following properties:
  • Copolymers of polytetrafluoroethylene and hexafluoropropylene are also suitable.
  • Suitable polytetrafluoroethylene material as outlined above is available from the William Gore Company, Elkton, Maryland.
  • polyamide materials are also sufficiently impervious to bacteria attack that they are useful in the present invention.
  • suitable polyamide materials include wound filters of this material which are available from Anlagensinstitut Berghof GmbH., Teubingen, West Germany and tubes of this material which are available from Kalle, Wiesbaden, West Germany.
  • the amount of recycled deionized water can be reduced and the amount of such water which passes through the membrane can be increased to increase the amount of sterile permeate produced by the invention. It has been found that as much as 70-90% of the deionized water can be passed through the membrane and still result in the consistent production of highly sterile, bacteria and pyrogen free permeate which is suitable for medicinal injection purposes. This is particularly true where the deionized water is caused to turbulently contact the inlet side of the membrane by well known techniques.
  • cooling is to be carried out due to lengthy recycling of either or both the deionized water or sterile permeate, it may be accomplished, for example, by recycling the water to a point upstream of the deionization plant. If other facilities for the cooling of the circuit water are present in the region where this plant is used, then these can of course be utilized.
  • the circuit arrangement of the excess portion of the deionized water conducted to the reverse osmosis and also the parallel circuit for the permeate include as much as possible of the equipment necessary for carrying out the process, in order that dead spaces shall be avoided and germs shall not be capable of collecting anywhere.
  • the equipment is composed of components and materials of known types, and also the valves are of known construction. Non-rusting steel, glass or quartz glass are preferably used as the materials.
  • a compensating vessel of the smallest practicable capacity with a level controller is contained in the circuit of the excess portion of the water to compensate for fluctuation in volume.

Abstract

In a process and apparatus for obtaining sterilized and bacteria-free water suitable for medicinal injections and other purposes, deionized water is supplied to a reverse osmosis filter, which is impervious to attack by bacteria and which is arranged such that its entire surface may be sterilized, to obtain a sterile permeate and a portion of the deionized water supplied to the filter is recycled. The recycled portion of deionized water may be recycled through the deionization plant from which it is derived or through a closed circuit and may be recycled in combination with the sterile permeate.

Description

RELATED APPLICATION
This application is a continuation-in-part of my copending application Ser. No. 934,350, filed Aug. 17, 1978, now abandoned.
FIELD OF THE INVENTION
This invention relates to a process and apparatus for obtaining highly pure, sterilized, particle, pyrogen and germ-free water for medicinal injection preparations and other technical purposes, using completely salt-free or deionized water and a reverse osmosis filter.
BACKGROUND & SUMMARY OF THE INVENTION
For the production of sterilized, bacteria-free and apyrogenic water, such as is required for injection and infusion solutions, it has been proposed that the so-called reverse osmosis or hyperfiltration may be used.
Reverse osmosis using semipermeable membranes has been employed in which water of low salt content is separated from a salt-containing water. If such a membrane is subjected to a salt containing water under a pressure exceeding the osmotic pressure of the solution, water of low salt content passes through and germs or bacteria and pyrogens are also retained by the membrane.
Reverse osmosis can be used to remove germs, bacteria and pyrogens from water which has previously been deionized by any conventional means.
Membranes which have been used for this purpose have been formed of acetyl celluloses, polyamides or polyolefins. Water transportation through the membranes is impeded by the concentration or polarization that occurs of retained substances. By a suitable excess flow oriented tangentially to the surface, such concentration and polarization can be reduced and the membrane surface can be largely kept clear of microscopic and larger bodies such as germs, bacteria and pyrogens.
The disadvantage of the known processes and apparatus comprising the semipermeable membranes is, however, that the membranes must be continually subjected to the action of water, in order that the semipermeable membranes are not damaged by bacteria which are unable to pass through the membranes. If the installation is shut down and no water flow takes place over the membrane, colonies of bacteria can form which attack the membrane, so that when operation is resumed germs will pass through the fairly large holes which are now present. On the other hand, a requirement for such pure water usually does not exist continuously, or the requirement for pure water is highly fluctuating, so that a solution must be found for collecting and storing the sterile permeate under sterile conditions.
Storage of the sterile permeate has normally been done in containers maintained under sterile conditions with the permeate in the containers at an elevated temperature, preferably 85° C., while it is stored. Such storage is not particularly economical. The provision of storage vessels for the sterilized permeate incurs capital costs and also the vessels occupy valuable space. Additionally, the vessels must be kept sterile. The energy consumption is considerable both for heating and maintaining the temperature at 85° C. and also for cooling the permeate when required for the intended purposes.
A further disadvantage is that, due to the particular nature of the above-described process of reverse osmosis, a considerable proportion of the water supplied to the semipermeable membrane serves only as excess water for maintaining at the surface of the membrane a flow of water for the above-mentioned reasons.
Systems in which a portion of the deionized water which is supplied to the reverse osmosis filter or membrane has been recycled to maintain the membrane as free as possible of bacteria and pyrogens which have been retained on the filter to minimize the possibility of bacteria attack on the filter are disclosed, for example, in French Pat. No. 2,207,868 and Marquardt, K., Moderne Wasseraufbereitung in zentralen Dialysestationen durch Umkehrosmose-Anlagen, Hager and Elsasser GmbH, Stuttgart, Heft 4/76. In addition, the latter cited German publication also discloses a system in which sterile permeate may be recycled to eliminate the need for storage vessels and their attendant disadvantages during periods of low sterile permeate demand.
Although the last mentioned systems have solved some of the problems which exist in the removal of bacteria using reverse osmosis filters or membranes, they have not successfully solved all of the problems that must be overcome in order for such membrane systems to be fully accepted for the preparation of water which is of sufficient purity for use in the injection of medicinals into the human body. Although such reverse osmosis filters or membranes have been accepted by the United States Pharmacopoeia for the preparation of pyrogen-free water for injection, they have not been accepted for the preparation of bacteria-free water for this purpose. Goodall, J., Process Water Purification; RO Techniques and Economics, Proceedings of the Filtration Society, 1977, p. 652.
The present inventor has discovered that even though recycling of a portion of the deionized water removes substantial amounts of bacteria from the filter surfaces and reduces the likelihood of attack on the membrane, some bacteria still remains which will attack the membrane and eventually a certain amount of bacteria will enter the permeate at these points of attack. Moreover, in the prior systems it has been generally necessary to recycle a substantial amount of the deionized water to insure that a sufficient flushing action occurs at the membrane surface to delay for as long as possible attack of the membrane by the bacteria. Such substantial recycling of the deionized water is not only wasteful of pumping energy, but also results in reduced system capacity and increased cooling requirements to cool the recycled water which is heated by the pumping energy necessitated by such recycling.
The inventor has also discovered that where sterilizing fluids have been periodically employed to flush the prior systems, that the membranes of these systems were not of sufficient configuration to enable the sterilant to reach all portions of the membrane surfaces. Thus, the membranes were subjected to attack by bacteria on those portions of their surfaces which could not be reached by the sterilizing fluid and bacteria escaped into the permeate.
The process and apparatus incorporating the principles of the present invention is capable of producing a consistently sterile, bacteria and pyrogen-free permeate suitable for medicinal injections and other purposes contrary to the aforementioned Goodall publication and overcome all of the aforementioned disadvantages of the prior systems. The process and apparatus incorporating the principles of the present invention achieves this result while at the same time minimizing energy and capital requirements and maximizing capacity.
In one principal aspect of the present invention, a process for producing sterilized water free of bacteria and pyrogens and suitable for medicinal injection includes the step of circulating deionized water into contact with a reverse osmosis-filter formed of a material which is substantially impervious to attack by bacteria in the water. A portion of the deionized water is passed through the filter to obtain a sterile permeate and another portion is recycled from the filter. The sterile permeate which is not used is also recycled to the filter. At least periodically all portions of the surface of the filter are sterilized with a sterilizing fluid.
In another principal aspect of the present invention, apparatus for producing sterilized water free of bacteria and pyrogens and suitable for medicinal injection comprises a source of deionized water, a reverse osmosis filter formed of a material which is substantially impervious to attack by bacteria in the water, means for supplying the deionized water from the source to and into contact with the filter and passing a portion of the deionized water through the filter to obtain a sterile permeate. The apparatus also includes means for recycling another portion of the water which is not passed through the filter from the filter and means removes the sterile permeate from the filter withdraws the permeate for use and recycles the remainder of the permeate to the filter. Means at least periodically supplies a sterilizing fluid to the filter and the filter is constructed and arranged such that all portions of its surface are exposed to the sterilizing fluid.
In another principal aspect of the present invention, the filter which is impervious to bacteria attack is formed of a fluorine substituted polymer.
In still another principal aspect of the present invention, the filter is arranged in coil or plate form to enable the sterilizing fluid to reach all portions of the surface thereof.
These and other objects, features and advantages of the present invention will become apparent when considering the following detailed description of a preferred embodiment.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic diagram illustrating the operation of the preferred embodiment of the invention for obtaining pure water, the path of the supplied deionized water being shown in chain-dotted lines and the path of the permeate in dotted lines,
FIG. 2 is a view similar to FIG. 1 and illustrates the operation when no permeate is being removed, but deionized water is being supplied from a deionization plant,
FIG. 3 is a view similar to FIG. 2 and illustrates the operation when no deionized water is supplied from the plant, and
FIG. 4 is a view similar to FIG. 3 and illustrates the operation when the circuit is being sterilized.
DESCRIPTION OF THE PREFERRED EMBODIMENT
In FIGS. 1 and 2, deionized water which is derived from a deionization plant P and which is to be treated is supplied along an inlet line 1 and flows in the direction of the arrow through a shut-off valve V1, a solenoid valve MV1 and a non-return valve R1 into a supply line 9 which includes a pressure-reducing valve RV, a further shut-off valve V2 and a first prefilter VF1. The water leaving the prefilter VF1 flows into a second prefilter VF2, through a shut-off valve V3 and finally through a sampling station StE1 to a pump DP2 which generates the pressure necessary for operating the reverse osmosis filters RO1 and RO2, the pressure being between 10 and 80 bars according to the type of filter.
Only a portion of the deionized water supplied passes as permeate through the reverse osmosis filters and a discharge line 2 and an outlet line 5 incorporating valves MV2 and V6. A further sterile sampling station StE2 is contained in the discharge line 2.
The balance of the supplied deionized water flows through line 3 and a valve V4 into a compensating vessel B and fills this vessel until the upper level mark NRo of the level regulator is reached. The vessel B has an outlet communicating with a return line 6 which includes a pump DP1 which is switched on by the level regulator NRo when a predetermined liquid level is reached so that liquid is returned along line 6 into the deionization plant P until the level NRu is reached in the vessel B. This return flow along line 6 passes through a non-return valve R3, a solenoid valve MV4 and a shut-off valve V7. Between the solenoid valve MV4 and the shut-off valve V7 an emptying line containing a shut-off valve V8 is incorporated as a branch. Before, between, and after the prefilters VF1 and VF2, manometers M1 to M3 are preferably disposed as illustrated.
In the operation of the circuit shown in FIG. 1, permeate is drawn off along outlet line 5 for use and a portion of the supplied deionized water is recycled along return line 6 to the deionization plant P.
In FIG. 2, the circuit arrangement is shown when no permeate is drawn from the outlet line 5, but the deionization plant P is still in operation. In order to avoid the expense initially described of storage tanks and keeping them at a temperature of 85° C., a recycle line 4 connects the discharge line 2 to the compensating vessel B and is branched off between the sterile sampling station StE2 and the valve MV2, just upstream of the latter. In this recycle line, a solenoid valve MV3 is disposed, which is open when no permeate is drawn off, but is closed when permeate is drawn off. It should be mentioned here that this recycle line for the permeate branches off very close to and upstream of the valve MV2, in order that stationary water between the branch and the solenoid valve MV2 shall be avoided and the maximum volume of the plant shall be in the flowing state, so that growth of germs and bacteria is not favoured.
It will be appreciated that FIG. 2 illustrates the operating state in which no permeate is being withdrawn and the permeate together with a proportion of the supplied deionized water is supplied to the deionization plant P which is supplying the deionized water.
In the condition illustrated in FIG. 3, no deionized water is derived from or returned to the deionization plant P. A short-circuit line 8 incorporating a normally closed solenoid valve MV5 and a non-return valve R2 connects the return line 6 to the supply line 1 from a position upstream of the non-return valve R3 to a position between the valves R1 and RV. In this case, the pressure PD1 sensed by the pressure monitor D1 is smaller than a predetermined critical pressure PD1 crit., and this operates to close valves MV1 and MV4 and open valve MV5. Also, MV2 is closed or held closed and MV3 is opened or held open. In addition, in order to prevent harmful heating up of the plant, the pump DP2 is switched off.
The pump DP1 maintains a weak circulation through the entire plant, as can be seen from the switching diagram below of the plant. In this condition of the circuit, the supplied deionized water and the permeate are circulated in a closed circuit or loop.
As can be seen from FIG. 3, the compensating vessel B is equipped with a connecting line 7, through which a sterilizing disinfecting agent, for example a 2% formalin solution, can be periodically introduced. This formalin solution, when supplied, flows out of the vessel B through the pump DP1, along the line 8 into the line 9 leading to the prefilters, through the pump DP2, and then partially as an excess portion back into the compensating vessel B, and also through the reverse osmosis filters RO1 and RO2, through the lines 2 and 4 back into the compensating vessel B, because the solenoid valve MV3 is opened, but the solenoid valve MV2 is closed.
In the line 7, a breathing filter AF is provided, through which a sterile ventilation of the compensating vessel B can be carried out.
It can be seen that when the pumps DP1 and DP2 are operating, a complete sterilization of the circuit of the plant and a wide-ranging sterilization of the entire plant by means of the formalin solution introduced through the line 7 is possible. There remain only short lengths of pipe and some valves in the supply line 1 for the fully deionized water and in the return line 6 leading back to the deionization plant P, as components which are not swept by this formalin solution. This defect can, however, be overcome at the lines near to the circuit, by causing these remaining portions to be traversed by the formalin solution when the plant is flushed through and by so arranging the line 8, which short-circuits the lines 9 and 6, that the proportion of non-sterilized pipe components and valves is kept as small as possible.
The change-over from the operating state according to FIGS. 1 and 2 into the operating state with its function according to FIG. 4 can be carried out in practice automatically either after the elapse of specific periods or after specific quantities have flowed through. When changing over from the state according to FIG. 1 or 2 into the state according to FIG. 4, the valves MV1, MV2 and MV4 would be closed and a disinfecting agent introduced into the compensating vessel through the line 7, optionally together with water as a diluting agent. The water contained in the plant can be entirely or partially discharged from the vessel B through a line 10 after opening a valve V5 in the line 10. The arrangement and layout should take account of this accordingly.
In the switching diagram given below, the four methods of operation of the plant are illustrated in a summary manner by indicating the position of the valves and the operating of the pumps. In this switching diagram, the terms are also explained and the references used in FIGS. 1 and 4 are summarized.
It has already been pointed out that an increase in temperature results from the circulation of the excess water and non-removed highly pure water or permeate. For this reason, the compensating vessel B or another location of the circuit may be equipped with a thermoprobe which measures the temperature of the water in the circuit and switches appropriate electric circuits which, by switching off pumps or switching on cooling means, leads to a reduction in the temperature of the water in the circuit.
In operating methods 3 and 4, a closed circuit exists through the short-circuit line 8. In such a case, water could escape continuously from the plant through a defect in any portion of it. In order to prevent consequent damage to the plant, and especially to the reverse osmosis filters, the level controller in the compensating vessel B can be equipped with a contact such as NRs for switching off the pressure pump DP1 and triggering an alarm.
Explanation of Abbreviations of Flow Diagram and Description of Functioning
PD1 crit.: critical pressure, which is smaller than the lowest full deionization water pressure with the deionization plant P in operation. Objective: switching over from operating method 1 or 2 to 3, when the deionization plant P goes out of operation or other pressure failure takes place upstream of D1.
PD2 crit.: critical pressure
For Operating Method 1: smaller than a maximum pressure of PD2
For Operating Method 2: smaller than the pressure set at pressure reducing valve RV
For Operating Method 3: smaller than the pressure set at pressure reducing valve RV
For Operating Method 4: as for operating method 1
Pu: excess flow pressure adjustable
o: valve opened
: valve closed
AF: breathing filter
VE: fully desalinated water
V: hand valve
MV: solenoid valve
RV: pressure reducing valve
VF: prefilter
StE: sterile sampling
DP: Pressure pump
RO: reverse osmosis plant
R: non-return valve
M: manometer
D: pressure switch
B: reject vessel
NR: level controller
NRo: level controller top
NRu: level controller bottom
NRs: level controller safety
In a specific embodiment of the plant for carrying out the process according to this invention, the two reverse osmosis filters RO1 and RO2, the pump DP2 and the return flow throttle valve V4 should be adapted to one another and may be designed, for example, for a permeation rate per hour of 80 l. The pump then produces a pressure of, for instance, 14 bars.
__________________________________________________________________________
SWITCHING DIAGRAM FOR PLANT FOR OBTAINING STERILE AQUA PRO INJECTIONS     
Method of                                                                 
functioning                                                               
      V1   D1 MV1                                                         
                 V2                                                       
                   V3                                                     
                     DP2                                                  
                        V4    D2 MV2                                      
                                    V6                                    
                                      MV3                                 
                                         NR AF  V5                        
                                                  DP1                     
                                                     MV4                  
                                                        V7                
                                                          V8 MV5          
__________________________________________________________________________
1 Draw-off                                                                
        PD1                                                               
           >               PD2                                            
                              <          top                              
                                            conn- on                      
of sterile                                                                
      o PD1                                                               
           crit.                                                          
              o  o o on PU PD2                                            
                              crit.                                       
                                 o  o •                             
                                         bot-                             
                                            ected                         
                                                •                   
                                                  off                     
                                                     o       o            
                                                     • •      
aqua pro                                 tom                              
injections                                                                
full                                                                      
deionisation                                                              
in                                                                        
operation                                                                 
2 No draw-                                                                
        PD1                                                               
           >               PD2                                            
                              <          top                              
                                            conn- on                      
off of                                                                    
      o PD1                                                               
           crit.                                                          
              o  o o on PU PD2                                            
                              crit.                                       
                                 •                                  
                                    o o  bot-                             
                                            ected                         
                                                •                   
                                                  off                     
                                                     o       o            
                                                     • •      
sterile                                  tom                              
aqua pro                                                                  
injections;                                                               
full                                                                      
deionisation                                                              
plant in                                                                  
operation                                                                 
3 Full                                                                    
      o PD1                                                               
           ≦                                                       
              •                                                     
                 o o off                                                  
                        PU PD2                                            
                              <  •                                  
                                    o o  top    •                   
                                                  on • o            
                                                     • o            
deionisation                                                              
        PD1                                                               
           crit.           PD2                                            
                              crit.      bot-                             
                                            conn- off                     
plant not in                             tom                              
                                            ected                         
operation                                safe-                            
                                         ty                               
4 Chemical                                                                
      •                                                             
        PD1                                                               
           ≦                                                       
              •                                                     
                 o o on PU PD2                                            
                              <  •                                  
                                    o o  top                              
                                            not •                   
                                                  on • •      
                                                     • o            
sterilisation                                                             
           >                     /    /  bot-                             
                                            conn-                         
                                                /    /       /            
                                                     /                    
of plant                                                                  
        PD1                                                               
           crit.     off   PD2                                            
                              crit.                                       
                                 o    •                             
                                         tom                              
                                            ected                         
                                                o off                     
                                                     o       o            
                                                     •              
with                                     safe-                            
formalin                                 ty                               
__________________________________________________________________________
The volume of the compensating vessel B is then, for example 100 l and the total volume of the plant will be 120 l, depending upon the length of the lines 2 and 4. The pump DP1 is designed according to the characteristics of the reverse osmosis filters and the flocking characteristic of the pump DP2, that is the characteristic when this pump is shut down.
The process and apparatus of the present invention offers a system in which the recycling of a portion of the dionized water with or without the permeate impairs colonies of bacteria forming at the membrane of the reverse osmosis filter even under circumstances where there is no demand for the permeate. However, as previously mentioned, it has been found that such recycling of deionized water is not sufficient to prevent eventual attack of the membrane by colonies of bacteria. In the present invention, it has been discovered that this attack can be prevented by two additional features. One feature is to employ a membrane material which is substantially impervious to bacteria attack so that even if some bacterial growth is experienced on the membrane, the membrane will remain intact. The other feature is to employ a membrane construction and arrangement which can be contacted over its entire surface by the sterilizing disinfecting agent during the sterilizing portion of the cycle of operation.
It has been found that a reverse osmosis filter or membrane formed of a halogenated polymer is substantially impervious to bacteria attack. A preferred membrane material for this purpose, and to which bacteria do not easily attach, is a fluorine substituted polymer. Such membrane sheets may be formed as described in 21 Journal of Applied Polymer Science, 1977, pp. 3269-3290.
Some examples of membrane materials which are suitable for use in the present invention include homo- and copolymers of polytetrafluoroethylene and polytrifluorochroroethylene. One suitable example of polytetrafluoroethylene may have the following properties:
______________________________________                                    
Density:             2.0 to 2.3                                           
Temperature Resistance:                                                   
                     -100° to +260° C.                      
Load Carrying Capacity                                                    
According to Vicat VDE-                                                   
Norm 0302 (German                                                         
Standard):           110° C.                                       
Heat Loading Capacity or                                                  
Heat Distortional Tempera-                                                
ture (according to ASTM D 648)                                            
At 166 PSI:          130° to 190° C.                        
At 264 PSI:          50° to 60° C.                          
Refractory Index:    1.35                                                 
(according to German                                                      
Standard DIN (53491)                                                      
______________________________________                                    
and a suitable example of polytrifluorochloroethylene may have the following properties:
______________________________________                                    
Density:          2.0 to 2.1                                              
Melting Point     about 212° C.                                    
Load Carrying Capacity                                                    
according to Vicat VDE-                                                   
Norm 0302 (German                                                         
Standard):        76° to 89° C.                             
According to Martens DIN                                                  
53458:            56° to 64° C.                             
Heat Distortional Tempera-                                                
ture at 264 PSI:  50° to 58° C.                             
Temperature Resistance:                                                   
                  Between +150° and -40° C.                 
Refractory Index: 1.425                                                   
Thickness of Foil:                                                        
                  Between 50 and 100 microns                              
______________________________________                                    
Copolymers of polytetrafluoroethylene and hexafluoropropylene are also suitable.
Suitable polytetrafluoroethylene material as outlined above is available from the William Gore Company, Elkton, Maryland.
Some polyamide materials are also sufficiently impervious to bacteria attack that they are useful in the present invention. Such suitable polyamide materials include wound filters of this material which are available from Forschungsinstitut Berghof GmbH., Teubingen, West Germany and tubes of this material which are available from Kalle, Wiesbaden, West Germany.
It has also been discovered that current reverse osmosis membranes of the hollow fiber type are not suitable for the production of the bacteria-free permeate desired by the present invention. Current hollow fiber membranes cannot be completely sterilized by the sterilizing disinfecting agent because such agent cannot reach all of the surfaces of the membrane. It has been found, however, that membranes arranged either in flat sheets or plates or in spiral or coil form can be easily and completely sterilized because the sterilizing disinfecting agent can reach all of the surfaces of the membrane during the sterilizing portion of the cycle. Thus, the latter mentioned membrane arrangements are preferred. Suitable flat sheet and spiral or coil osmosis cell apparatus is available from the firms Satorius, GmbH, Goettingen, Germany and Deutsche Millipore GmbH, Neuisenburg, Germany.
Due to the fact that in the present invention, recycling of a portion of the deionized water which contacts the membrane is not the sole feature relied upon to prevent bacteria attack and damage to the filter, the amount of recycled deionized water can be reduced and the amount of such water which passes through the membrane can be increased to increase the amount of sterile permeate produced by the invention. It has been found that as much as 70-90% of the deionized water can be passed through the membrane and still result in the consistent production of highly sterile, bacteria and pyrogen free permeate which is suitable for medicinal injection purposes. This is particularly true where the deionized water is caused to turbulently contact the inlet side of the membrane by well known techniques. By minimizing the amount of recycled deionized water and maximizing the flow through the membrane, energy consumption and capital requirements of the process and apparatus are minimized and capacity is maximized.
It will be understood that if cooling is to be carried out due to lengthy recycling of either or both the deionized water or sterile permeate, it may be accomplished, for example, by recycling the water to a point upstream of the deionization plant. If other facilities for the cooling of the circuit water are present in the region where this plant is used, then these can of course be utilized.
The circuit arrangement of the excess portion of the deionized water conducted to the reverse osmosis and also the parallel circuit for the permeate include as much as possible of the equipment necessary for carrying out the process, in order that dead spaces shall be avoided and germs shall not be capable of collecting anywhere. The equipment is composed of components and materials of known types, and also the valves are of known construction. Non-rusting steel, glass or quartz glass are preferably used as the materials.
It will also be understood that a compensating vessel of the smallest practicable capacity with a level controller is contained in the circuit of the excess portion of the water to compensate for fluctuation in volume.
Although a preferred embodiment of the invention has been described in detail, the invention is not to be limited to only such embodiment, but rather only by the appended claims.

Claims (19)

What is claimed is:
1. A process for producing sterilized water free of bacteria and pyrogens and suitable for medicinal injection comprising the steps of:
circulating deionized water to be sterilized into contact with a reverse osmosis non-hollow, non-fibrous filter formed of a material which is substantially impervious to attack by bacteria in the water,
passing a portion of said deionized water through said filter to obtain a sterile permeate,
recycling another portion of said deionized water from said filter,
recycling the sterile permeate which is not used to said filter, and
at least periodically sterilizing all portions of the surface of said filter with a sterilizing fluid.
2. A process according to claim 1 in which the deionized water is derived from a deionization plant.
3. A process according to claim 1 in which the recycled sterile permeate is combined with said recycled portion of the deionized water.
4. A process according to claim 3 in which the said recycled sterile permeate is combined with said recycled portion of the deionized water in a compensating vessel.
5. A process according to claim 1 in which said filter is formed of a halogen substituted polymer.
6. A process according to claim 5 in which said halogen is fluorine.
7. A process according to claim 5 in which said halogen substituted polymer is polytetrafluroethylene.
8. The process according to claim 1 wherein said filter is arranged in coil or plate form to enable said sterilizing fluid to reach all portions of the surface thereof.
9. A process according to claim 1 in which the deionized water is derived from a deionization plant and said recycled permeate is combined with said recycled portion of the deionized water, in which said portion of said deionized water which is passed through said filter comprises 70-90% of the deionized water which is circulated into contact with said filter, in which said deionized water turbulently contacts said filter, and in which said filter is formed of a fluorine substituted polymer and is arranged in coil or plate form to enable said sterilizing fluid to reach all portions of the surface thereof.
10. A process according to claim 1 in which said portion of said deionized water which is passed through said filter comprises 70-90% of the water which is circulated into contact with said filter.
11. A process according to claim 1 in which said deionized water turbulently contacts said filter.
12. Apparatus for producing sterilized water free of bacteria and pyrogens and suitable for medicinal injection comprising:
a source of deionized water,
a reverse osmosis filter formed of a material which is substantially impervious to attack by bacteria in the water,
means for supplying deionized water from said source to and into contact with said filter and passing a portion of said deionized water through said filter to obtain a sterile permeate,
means for recycling another portion of said water which is not passed through said filter from said filter,
means for removing said sterile permeate from said filter, said last mentioned means including means for withdrawing sterile permeate for use and recycling the remainder of said sterile permeate to said filter,
means for at least periodically supplying a sterilizing fluid to said filter, said filter being constructed and arranged such that all portions of the surface of said filter are exposed to said sterilizing fluid,
a compensating vessel,
an outlet line for removing said sterile permeate for use,
a recycle line connecting the sterile permeate side of said filter to said compensating vessel,
a second recycle line connecting said means for supplying deionized water to said compensating vessel,
a return line connecting said compensating vessel to said source,
a short-circuit line connecting said return line to said means for supplying deionized water,
first valve means in said outlet line selectively operable to open and close said outlet line,
second valve means in said the first mentioned recycle line selectively operable to close and open the first mentioned recycle line, and
third valve means selectively operable to close and open said short-circuit line.
13. Apparatus according to claim 12 including fourth valve means in said means for supplying deionized water upstream of said connection to said short-circuit line and operable to open and close said means for supplying deionized water, and fifth valve means in said return line downstream of said connection to said short-circuit line and operable to open and close said return line.
14. Apparatus according to claim 12 including a pump in said return line upstream of said connection to said short-circuit line and a level controller associated with said compensating vessel and responsive to the liquid level therein to control said pump and maintain said liquid level below a predetermined value.
15. Apparatus according to claim 12 including a first liquid sampling station in said means for supplying deionized water and a second liquid sampling station in said outlet line.
16. Apparatus for producing sterilized water free of bacteria and pyrogens and suitable for medicinal injection comprising:
a source of deionized water,
a reverse osmosis non-hollow, non-fibrous filter formed of a material which is substantially impervious to attack by bacteria in the water,
means for supplying deionized water from said source to and into contact with said filter and passing a portion of said deionized water through said filter to obtain a sterile permeate,
means for recycling another portion of said water which is not passed through said filter from said filter,
means for removing said sterile permeate from said filter, said last mentioned means including means for withdrawing sterile permeate for use and recycling the remainder of said sterile permeate to said filter,
means for at least periodically supplying a sterilizing fluid to said filter, all portions of the surface of said non-hollow, non-fibrous filter being exposed to said sterilizing fluid,
a compensating vessel,
an outlet line for removing said sterile permeate for use,
a recycle line connecting the sterile permeate side of said filter to said compensating vessel,
a second recycle line connecting said means for supplying deionized water to said compensating vessel,
a return line connecting said compensating vessel to said source,
a short-circuit line connecting said return line to said means for supplying deionized water,
first valve means in said outlet line selectively operable to open and close said outlet line,
second valve means in said first-mentioned recycle line selectively operable to close and open the first-mentioned recycle line, and
third valve means selectively operable to close and open said short-circuit line.
17. Apparatus according to claim 16 including fourth valve means in said means for supplying deionized water upstream of said connection to said short-circuit line and operable to open and close said means for supplying deionized water, and fifth valve means in said return line downstream of said connection to said short-circuit line and operable to open and close said return line.
18. Apparatus according to claim 16 including a pump in said return line upstream of said connection to said short-circuit line and a level controller associated with said compensating vessel and responsive to the liquid level therein to control said pump and maintain said liquid level below a predetermined value.
19. Apparatus according to claim 16 including a first liquid sampling station in said means for supplying deionized water and a second liquid sampling station in said outlet line.
US06/130,390 1977-09-01 1980-03-14 Process and apparatus for producing sterilized and bacteria-free water Expired - Lifetime US4342651A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2739335 1977-09-01
DE2739335A DE2739335B2 (en) 1977-09-01 1977-09-01 Process for obtaining germ-free and particle-free water for medical injections and for technical purposes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US05934350 Continuation-In-Part 1978-08-17

Publications (1)

Publication Number Publication Date
US4342651A true US4342651A (en) 1982-08-03

Family

ID=6017827

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/130,390 Expired - Lifetime US4342651A (en) 1977-09-01 1980-03-14 Process and apparatus for producing sterilized and bacteria-free water

Country Status (8)

Country Link
US (1) US4342651A (en)
JP (1) JPS5448955A (en)
CA (1) CA1096517A (en)
CH (1) CH629390A5 (en)
DE (1) DE2739335B2 (en)
FR (1) FR2401877A1 (en)
GB (1) GB2005154B (en)
IT (1) IT1099313B (en)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610790A (en) * 1984-02-10 1986-09-09 Sterimatics Company Limited Partnership Process and system for producing sterile water and sterile aqueous solutions
US4773993A (en) * 1984-08-31 1988-09-27 Hitachi, Ltd. Apparatus for purifying and dispensing water with stagnation preventing means
US4773991A (en) * 1987-03-13 1988-09-27 Baxter Travenol Laboratories, Inc. Water purification system fluid path
US4784763A (en) * 1987-07-13 1988-11-15 Labconco Corporation Water purification machine
US4784771A (en) * 1987-08-03 1988-11-15 Environmental Water Technology, Inc. Method and apparatus for purifying fluids
US4789014A (en) * 1986-12-05 1988-12-06 Baxter International Inc. Automated system for adding multiple fluids to a single container
US5056568A (en) * 1986-12-05 1991-10-15 Clintec Nutrition Company Automated system for adding multiple fluids to a single container
US5076332A (en) * 1986-12-08 1991-12-31 Clintec Nitrition Co. Arch geometry to eliminate tubing influence on load cell accuracy
US5085784A (en) * 1989-04-07 1992-02-04 Cuno, Incorporated Use of cationic charge modified filter media
US5490921A (en) * 1993-04-30 1996-02-13 Kioritz Corporation Two water purifying, recirculating and heating apparatus
US5685987A (en) * 1996-09-24 1997-11-11 Tresco, Llc Method for recycling formalin
WO1998051394A1 (en) * 1997-05-16 1998-11-19 Pure Water, Inc. Water distiller system for medical applications
US5888401A (en) * 1996-09-16 1999-03-30 Union Camp Corporation Method and apparatus for reducing membrane fouling
US5958232A (en) * 1996-12-27 1999-09-28 Chen; Kai Rui Reverse osmosis drinking water treatment system with backwashable precise prefilter unit
US6299766B1 (en) * 2000-07-06 2001-10-09 Clark Permar Reverse osmosis filtering apparatus with concentrate dilution
US20020104271A1 (en) * 1999-04-22 2002-08-08 Gallant Dennis J. Modular patient room
WO2004037726A1 (en) * 2002-10-23 2004-05-06 Usfilter Corporation Production of water for injection using reverse osmosis
EP1614437A1 (en) * 2004-07-08 2006-01-11 Peter Taboada, S.l. Water treatment system for haemodialysis
US7744760B2 (en) 2006-09-20 2010-06-29 Siemens Water Technologies Corp. Method and apparatus for desalination
US20110162964A1 (en) * 2007-11-30 2011-07-07 Evgeniya Freydina Systems and methods for water treatment
US8045849B2 (en) 2005-06-01 2011-10-25 Siemens Industry, Inc. Water treatment system and process
US20110300231A1 (en) * 2010-06-07 2011-12-08 State University and Home Dialysis Plus, Ltd. Fluid purification system
US20120145636A1 (en) * 2010-12-10 2012-06-14 Water Intellectual Properties, Inc. High Efficiency Water Purification System
US8215065B2 (en) 1999-04-22 2012-07-10 Hill-Rom Services, Inc. Modular wall unit
US20140172178A1 (en) * 2011-06-30 2014-06-19 Coway Co., Ltd. Control method of an in-house device using a control kit and control method for a water purifier using a control kit
US9023185B2 (en) 2006-06-22 2015-05-05 Evoqua Water Technologies Llc Low scale potential water treatment
US9328969B2 (en) 2011-10-07 2016-05-03 Outset Medical, Inc. Heat exchange fluid purification for dialysis system
US9402945B2 (en) 2014-04-29 2016-08-02 Outset Medical, Inc. Dialysis system and methods
US9545469B2 (en) 2009-12-05 2017-01-17 Outset Medical, Inc. Dialysis system with ultrafiltration control
US11534537B2 (en) 2016-08-19 2022-12-27 Outset Medical, Inc. Peritoneal dialysis system and methods
US11684892B2 (en) 2016-12-01 2023-06-27 Pentair Residential Filtration, Llc Water filtration system and method

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128994C2 (en) * 1981-07-22 1986-01-02 Grünbeck Wasseraufbereitung GmbH, 8884 Höchstädt System separation device
EP0088979A1 (en) * 1982-03-12 1983-09-21 Herco W. Herrmann &amp; Co. GmbH Process for the treatment of aqueous solutions, particularly water
JP2002316152A (en) * 2001-04-19 2002-10-29 Nikkiso Co Ltd Refined water making apparatus
JP2012196678A (en) * 2012-07-25 2012-10-18 Miura Co Ltd Operation method for membrane filtration system, and membrane filtration system

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639231A (en) * 1970-11-13 1972-02-01 Bresler And Associates Inc Desalination process
UST912007I4 (en) 1972-10-03 1973-07-10 Flow dividers in memrrane permeation separation apparatus
FR2207868A1 (en) * 1972-11-24 1974-06-21 Sadon A Ets Demineralised sterile water prodn. plant - operating by reverse osmosis appts. and ion exchangers
US3849305A (en) * 1972-05-23 1974-11-19 S Manjikian Reverse osmosis water purifying system for household use
US4072610A (en) * 1975-05-01 1978-02-07 Ingerthorpe Holdings Limited Production of solutions
US4160727A (en) * 1976-02-21 1979-07-10 Foremost-Mckesson, Inc. Method and apparatus utilizing staged reverse osmosis units for purifying and dispensing water
US4166031A (en) * 1976-05-21 1979-08-28 Dean Hardy Artificial kidney cleaning apparatus and process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3774763A (en) * 1970-10-15 1973-11-27 Culligan Int Co Water purification system
FR2224411A1 (en) * 1973-04-05 1974-10-31 Sadon Ste Nle Ets A Deionising and sterilising water - by decationising, degassing and subjecting to reverse osmosis
FR2309238A1 (en) * 1975-05-02 1976-11-26 Gow James Aq. solns. for medical purposes - using water passed through reverse osmosis column to retain pyrogenic materials
DE2737121A1 (en) * 1977-08-17 1979-03-01 Erich Alhaeuser METHOD AND DEVICE FOR PRODUCING PYROGEN-FREE STERILE WATER

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639231A (en) * 1970-11-13 1972-02-01 Bresler And Associates Inc Desalination process
US3849305A (en) * 1972-05-23 1974-11-19 S Manjikian Reverse osmosis water purifying system for household use
UST912007I4 (en) 1972-10-03 1973-07-10 Flow dividers in memrrane permeation separation apparatus
FR2207868A1 (en) * 1972-11-24 1974-06-21 Sadon A Ets Demineralised sterile water prodn. plant - operating by reverse osmosis appts. and ion exchangers
US4072610A (en) * 1975-05-01 1978-02-07 Ingerthorpe Holdings Limited Production of solutions
US4160727A (en) * 1976-02-21 1979-07-10 Foremost-Mckesson, Inc. Method and apparatus utilizing staged reverse osmosis units for purifying and dispensing water
US4166031A (en) * 1976-05-21 1979-08-28 Dean Hardy Artificial kidney cleaning apparatus and process

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Goodall et al., "Process Water - - - Economicas," from Filtration & Separation, Nov./Dec. 1977, pp. 649-655.
Marquardt et al., "Modern - - - Unkehrosmose Anlgen," Hager & Elsasser GmbH, Stuttgart, Heft, 4/76.
Vigo et al., Preparation of - - - Hyperfiltration," from J. Applied Polymer Science, vol. 21, 1977, pp. 3269-3290.

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610790A (en) * 1984-02-10 1986-09-09 Sterimatics Company Limited Partnership Process and system for producing sterile water and sterile aqueous solutions
US4773993A (en) * 1984-08-31 1988-09-27 Hitachi, Ltd. Apparatus for purifying and dispensing water with stagnation preventing means
US5056568A (en) * 1986-12-05 1991-10-15 Clintec Nutrition Company Automated system for adding multiple fluids to a single container
US4789014A (en) * 1986-12-05 1988-12-06 Baxter International Inc. Automated system for adding multiple fluids to a single container
US4967811A (en) * 1986-12-05 1990-11-06 Clintec Nutrition Company Automated system for adding multiple fluids to a single container
US5076332A (en) * 1986-12-08 1991-12-31 Clintec Nitrition Co. Arch geometry to eliminate tubing influence on load cell accuracy
US4773991A (en) * 1987-03-13 1988-09-27 Baxter Travenol Laboratories, Inc. Water purification system fluid path
US4784763A (en) * 1987-07-13 1988-11-15 Labconco Corporation Water purification machine
US4784771A (en) * 1987-08-03 1988-11-15 Environmental Water Technology, Inc. Method and apparatus for purifying fluids
US5085784A (en) * 1989-04-07 1992-02-04 Cuno, Incorporated Use of cationic charge modified filter media
US5490921A (en) * 1993-04-30 1996-02-13 Kioritz Corporation Two water purifying, recirculating and heating apparatus
US5888401A (en) * 1996-09-16 1999-03-30 Union Camp Corporation Method and apparatus for reducing membrane fouling
US5685987A (en) * 1996-09-24 1997-11-11 Tresco, Llc Method for recycling formalin
US5958232A (en) * 1996-12-27 1999-09-28 Chen; Kai Rui Reverse osmosis drinking water treatment system with backwashable precise prefilter unit
US6149809A (en) * 1996-12-27 2000-11-21 Chen; Kai Rui Water treatment system with backwashable precise prefilter unit
WO1998051394A1 (en) * 1997-05-16 1998-11-19 Pure Water, Inc. Water distiller system for medical applications
US8458962B2 (en) 1999-04-22 2013-06-11 Hill-Rom Services, Inc. Wall unit having concealable service outlets
US20020104271A1 (en) * 1999-04-22 2002-08-08 Gallant Dennis J. Modular patient room
US8215065B2 (en) 1999-04-22 2012-07-10 Hill-Rom Services, Inc. Modular wall unit
US7174678B2 (en) 1999-04-22 2007-02-13 Hill-Rom Services, Inc. Modular patient room
US7537030B2 (en) 1999-04-22 2009-05-26 Hill-Rom Services, Inc. Patient point-of-care water sterilizer
US6299766B1 (en) * 2000-07-06 2001-10-09 Clark Permar Reverse osmosis filtering apparatus with concentrate dilution
US7501061B2 (en) 2002-10-23 2009-03-10 Siemens Water Technologies Holding Corp. Production of water for injection using reverse osmosis
US7371319B2 (en) 2002-10-23 2008-05-13 Siemens Water Technologies Holding Corp. Production of water for injection using reverse osmosis
WO2004037726A1 (en) * 2002-10-23 2004-05-06 Usfilter Corporation Production of water for injection using reverse osmosis
EP1614437A1 (en) * 2004-07-08 2006-01-11 Peter Taboada, S.l. Water treatment system for haemodialysis
US8045849B2 (en) 2005-06-01 2011-10-25 Siemens Industry, Inc. Water treatment system and process
US9586842B2 (en) 2006-06-22 2017-03-07 Evoqua Water Technologies Llc Low scale potential water treatment
US9023185B2 (en) 2006-06-22 2015-05-05 Evoqua Water Technologies Llc Low scale potential water treatment
US7744760B2 (en) 2006-09-20 2010-06-29 Siemens Water Technologies Corp. Method and apparatus for desalination
US8182693B2 (en) 2006-09-20 2012-05-22 Siemens Industry, Inc. Method and apparatus for desalination
US20110162964A1 (en) * 2007-11-30 2011-07-07 Evgeniya Freydina Systems and methods for water treatment
US8585882B2 (en) 2007-11-30 2013-11-19 Siemens Water Technologies Llc Systems and methods for water treatment
US9011660B2 (en) 2007-11-30 2015-04-21 Evoqua Water Technologies Llc Systems and methods for water treatment
US9637400B2 (en) 2007-11-30 2017-05-02 Evoqua Water Technologies Llc Systems and methods for water treatment
US9545469B2 (en) 2009-12-05 2017-01-17 Outset Medical, Inc. Dialysis system with ultrafiltration control
US11724013B2 (en) 2010-06-07 2023-08-15 Outset Medical, Inc. Fluid purification system
US10105476B2 (en) 2010-06-07 2018-10-23 Oregon State University Fluid purification system
US8524086B2 (en) * 2010-06-07 2013-09-03 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Fluid purification system
US9138687B2 (en) 2010-06-07 2015-09-22 Oregon State University Fluid purification system
US20110300231A1 (en) * 2010-06-07 2011-12-08 State University and Home Dialysis Plus, Ltd. Fluid purification system
US20120145636A1 (en) * 2010-12-10 2012-06-14 Water Intellectual Properties, Inc. High Efficiency Water Purification System
US8691095B2 (en) * 2010-12-10 2014-04-08 Water Intellectual Properties, Inc. High efficiency water purification system
US20140172178A1 (en) * 2011-06-30 2014-06-19 Coway Co., Ltd. Control method of an in-house device using a control kit and control method for a water purifier using a control kit
US10310520B2 (en) * 2011-06-30 2019-06-04 Coway Co., Ltd Control method of an in-house device using a control kit and control method for a water purifier using a control kit
US9328969B2 (en) 2011-10-07 2016-05-03 Outset Medical, Inc. Heat exchange fluid purification for dialysis system
US9504777B2 (en) 2014-04-29 2016-11-29 Outset Medical, Inc. Dialysis system and methods
US9579440B2 (en) 2014-04-29 2017-02-28 Outset Medical, Inc. Dialysis system and methods
US9402945B2 (en) 2014-04-29 2016-08-02 Outset Medical, Inc. Dialysis system and methods
US11305040B2 (en) 2014-04-29 2022-04-19 Outset Medical, Inc. Dialysis system and methods
US11534537B2 (en) 2016-08-19 2022-12-27 Outset Medical, Inc. Peritoneal dialysis system and methods
US11951241B2 (en) 2016-08-19 2024-04-09 Outset Medical, Inc. Peritoneal dialysis system and methods
US11684892B2 (en) 2016-12-01 2023-06-27 Pentair Residential Filtration, Llc Water filtration system and method

Also Published As

Publication number Publication date
IT1099313B (en) 1985-09-18
FR2401877A1 (en) 1979-03-30
IT7827167A0 (en) 1978-08-30
DE2739335A1 (en) 1979-03-08
GB2005154A (en) 1979-04-19
JPS5448955A (en) 1979-04-17
GB2005154B (en) 1982-04-07
CA1096517A (en) 1981-02-24
CH629390A5 (en) 1982-04-30
DE2739335B2 (en) 1980-01-10

Similar Documents

Publication Publication Date Title
US4342651A (en) Process and apparatus for producing sterilized and bacteria-free water
US7501061B2 (en) Production of water for injection using reverse osmosis
US6074551A (en) Automatic cleaning system for a reverse osmosis unit in a high purity water treatment system
US7018529B2 (en) System for producing ultrapure water
US20140027379A1 (en) Ro system and method for disinfecting lines of the ro system
JP2001000969A (en) Reverse osmosis membrane type refined water making apparatus
JP2007125493A (en) Water purifying apparatus and its control method
JP2001239134A (en) Method for operating reverse osmosis treatment device, control device therefor and method for making water
US6485649B1 (en) Method and device for the production of pure water
JPH0427485A (en) Method for defoaming pure water and reverse osmosis method for production of pure water
JPH09206743A (en) Superpure water producing and supplying device and washing method thereof
JP3299093B2 (en) Pure water production method and pure water production equipment
JP2014124483A (en) Method of sterilizing pure water production apparatus for pharmaceuticals and pure water production apparatus for pharmaceuticals
KR100505324B1 (en) Method for water treatment and apparatus for water treatment
JP3547018B2 (en) Reverse osmosis treatment method and fresh water method
KR20180076121A (en) Water treatment apparatus
JPH10296060A (en) Prevention method for contamination of separation membrane
KR101305331B1 (en) Water purifier
JP3998997B2 (en) Disinfection method of ultrapure water supply pipe
JP2003071444A (en) Ultrapure water making system
JP6860648B1 (en) Water treatment system and water treatment method
JP3084014U (en) Aseptic purified cold seawater production equipment
KR20240040369A (en) Concentrated wastewater reduction device of RO system
JPH10109092A (en) Treatment device of water for mold conditioning
JP2018051450A (en) Device for producing purified water for medical use

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: AHRENS, ULRICH E., DR., WEIMARER STRABE 21, D-3257

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:BLUTSPENDEDIENTST DER LANDESVERBANDE DES DEUTSHEN ROTEN KREUZES NIEDERSACHEN OLDENBURG AND BREMEN GMBH;REEL/FRAME:004215/0729

Effective date: 19840109